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A total of 370 ticks, encompassing 7 species from 4 
genera, were collected during 2002–2006 from domestic 
animals and vegetation in the Taza region of northeastern 
Morocco. Rickettsial DNA was identiﬁ  ed in 101 ticks (27%) 
by sequencing PCR products of fragments of the citrate 
synthase and outer membrane protein genes of Rickettsia 
spp. Seven rickettsiae of the spotted fever group were iden-
tiﬁ  ed, including 4 pathogens: R. aeschlimannii in Hyalomma 
marginatum marginatum,  R. massiliae in Rhipicephalus 
sanguineus,  R. slovaca in Dermacentor marginatus, and 
R. monacensis in Ixodes ricinus. Two suspected pathogens 
were also detected (R. raoultii in D. marginatus and R. hel-
vetica in I. ricinus). An incompletely described Rickettsia sp. 
was detected in Haemaphysalis spp. ticks.
T
ick-borne rickettsioses are infections caused by obli-
gate intracellular gram-negative bacteria of the spot-
ted fever group (SFG) in the genus Rickettsia and the or-
der Rickettsiales. These zoonoses are now recognized as 
emerging vector-borne infections worldwide (1,2). They 
share characteristic clinical features, including fever, head-
ache, rash, and occasional eschar formation at the site of 
the tick bite. Although these diseases have been known for 
a long time, they have been poorly investigated in northern 
Africa, including Morocco (2).
Two human tick-borne SFG rickettsioses are known to 
occur in Morocco. Mediterranean spotted fever, caused by 
Rickettsia conorii conorii, is transmitted by the brown dog 
tick, Rhipicephalus sanguineus, which is well adapted to 
urban environments and is endemic to the Mediterranean 
area (2). In Morocco, clinicians usually consider patients 
with spotted fever as having Mediterranean spotted fever. 
However, in 1997, Beati et al. isolated a new rickettsia, R. 
aeschlimannii, from Hyalomma marginatum marginatum 
ticks collected in Morocco (3). In 2002, human infection 
with this rickettsia was reported in a patient returning from 
Morocco to France (4).
To date, all studies on rickettsioses conducted in 
Morocco have been based on only clinical and serolog-
ic features. However, the number of representatives of 
the genus Rickettsia and the number of newly described 
rickettsioses have increased in recent decades because of 
improved cell culture isolation techniques and extensive 
use of bacterial detection and identiﬁ  cation by molecular 
biologic techniques (2). Comparison of the sequences of 
PCR-ampliﬁ  ed fragments of genes encoding 16S rRNA, 
citrate synthase (gltA), or outer membrane protein (ompA) 
has become a reliable method for identifying rickettsiae in 
arthropods, including ticks (1). Therefore, our aim was to 
detect and characterize rickettsiae in hard ticks collected 
in Morocco by using PCR and sequence analysis of am-
pliﬁ  ed products and to discuss their potential threat for 
humans and animals.
Materials and Methods
Collection and Identiﬁ  cation of Ticks
From April 2002 through March 2006, ticks were 
collected from domestic animals (livestock and dogs) 
and by ﬂ  agging vegetation at sites in the Taza region in 
northeastern Morocco. These sites were located between 
the towns of Babboudir and Babezhare, (34°12′48.81′′N, 
4°0′55.63′′W) in the Atlas Mountains, situated 40 km from 
the city of Taza and 90 km from the city of Fez. All ticks 
collected were adults and morphologically identiﬁ  ed to the 
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species or genus level by using standard taxonomic keys. 
Ticks were kept in ethanol at room temperature until DNA 
was extracted in the Laboratoire des Maladies Vectorielles, 
Institut Pasteur du Maroc, Casablanca, Morocco. DNA 
samples were thereafter sent to the Unité des Rickettsies in 
Marseille, France.
PCR Detection and Identiﬁ  cation of Rickettsia spp.
Ticks were rinsed with distilled water for 10 min, 
dried on sterile ﬁ  lter paper in a laminar ﬂ  ow hood, and 
crushed individually in sterile Eppendorf (Hamburg, Ger-
many) tubes. DNA was extracted by using the QIAamp 
Tissue Kit (QIAGEN, Hilden, Germany) according to the 
manufacturer’s instructions. Rickettsial DNA was detect-
ed by PCR by using primers Rp CS.409p and Rp CS.1258n 
(Eurogentec, Seraing, Belgium), which amplify a 750-bp 
fragment of the gltA gene of Rickettsia spp. as described 
(5). All ticks positive for gltA were tested for the ompA 
gene of Rickettsia spp. by using primers Rr. 190.70 and 
Rr. 190.701, which amplify a 629–632-bp fragment (5). A 
negative control (distilled water instead of tick DNA tem-
plate) and a positive control (DNA from R. montanensis) 
were included in each test. All PCRs were conducted in 
Marseille by using the GeneAmp PCR System 2400 and 
9700 thermal cyclers (PerkinElmer, Waltham, MA, USA). 
Ampliﬁ  cation products were analyzed after electrophore-
sis on a 1% agarose gel stained with ethidium bromide. 
To identify detected Rickettsia spp., PCR products were 
puriﬁ  ed and sequencing was performed as described (5). 
All sequences obtained were assembled and edited with 
Auto Assembler software version 1.4 (PerkinElmer). Se-
quences were analyzed by BLAST (www.ncbi.nlm.nih.
gov/blast/Blast.cgi) sequencing analysis of sequences in 
the GenBank database.
Molecular Identiﬁ  cation of Ticks
To help identify the ticks at the species level, molecular 
tools were used for some ticks that had not been morpho-
logically identiﬁ  ed at the species level and that were posi-
tive for rickettsiae. Ampliﬁ  cation by PCR with T1B and 
T2A primers and sequencing of a 338-bp ampliﬁ  ed frag-
ment of the 12S rRNA gene of the ticks were performed as 
described (6).
Results
A total of 370 specimens representing 7 species and 
4 genera of ticks were collected. Tick species identiﬁ  ed 
by taxonomic keys included Rh. sanguineus (106 speci-
mens), Rh. bursa (76), Rh. turanicus (25), Haemaphysalis 
sulcata (79), Ha. punctata (6), Ixodes ricinus (14), and 
Dermacentor marginatus (11) (Figure). Some ticks, in-
cluding engorged females or damaged specimens, were 
identiﬁ  ed to genus only (18 Haemaphysalis sp. and 35 
Hyalomma  sp.). Most ticks (337) were collected from 
domestic animals; the rest were collected by ﬂ  agging of 
vegetation (Table).
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Figure. Distribution of ticks in Morocco from which rickettsial DNA was detected by PCR. A) Rhipicephalus sanguineus, B) Haemaphysalis 
sulcata, C) Ha. punctata, D) Ixodes ricinus, E) Hyalomma marginatum marginatum, F) Dermacentor marginatus. Green circles indicate 
areas where ticks were collected and found to harbor rickettsiae. Ovals indicate distribution of each tick species in which rickettsial DNA 
was detected by PCR.Spotted Fever Group Rickettsiae in Ticks, Morocco
Rickettsial DNA was detected in 101 (27%) of 370 
ticks by using a gltA PCR. Three (8.6%) of 35 Hyalomma 
spp. ticks contained rickettsia DNA with a gltA gene frag-
ment that was 99.1% (765/772 bp) similar to that of R. ae-
schlimannii and 100% similar to the ompA gene of R. ae-
schlimannii. A 237-bp fragment of tick mitochondrial 12S 
rDNA gene was obtained from one of the R. aeschliman-
nii–infected ticks. The sequence of this fragment enabled 
deﬁ  nitive identiﬁ  cation of the tick to the species level, with 
100% similarity to H. marginatum marginatum (GenBank 
accession no. AF150034).
Five (4.7%) of 106 Rh. sanguineus ticks were posi-
tive for rickettsial DNA by PCR. For all samples, sequence 
analyses showed 99.8% (636/637) similarity with the gltA 
sequence and 100% similarity with the ompA sequence of 
R. massiliae. One R. massiliae–infected tick was evaluated 
by PCR ampliﬁ  cation of the tick mitochondrial 12S rDNA 
gene; sequence analyses showed 99.6% (235/236) simi-
larity to the corresponding 12S rDNA of Rh. sanguineus 
(GenBank accession no. AF133056).
A total of 5 (45.5%) of 11 D. marginatus ticks con-
tained a rickettsia with a nucleotide sequence of gltA that 
was 99.2% (635/640 bp) similar to R. slovaca and 100% 
(533/533 bp) similar to the ompA sequence of R. slovaca. 
Rickettsial DNA was detected in 1 other specimen of D. 
marginatus. Ampliﬁ  ed gltA and ompA fragments were se-
quenced and showed 99.3% (560/564 bp) similarity with 
the gltA gene of R. raoultii and 100% similarity with the 
ompA gene of R. raoultii.
Five (35.7%) of 14 specimens of I. ricinus were posi-
tive by gltA PCR. Sequence analyses showed 100% homol-
ogy with the corresponding gltA sequence of R. monacen-
sis. OmpA sequences were obtained and showed 99.7% 
(585/587 bp) similarity with the corresponding sequence 
of R. monacensis. Four (28.6%) of 14 I. ricinus ticks con-
tained rickettsia with nucleotide sequences of gltA with 
99.8% (633/634 bp) similarity to R. helvetica. The primer 
set Rr.190.70p-Rr.190.701n failed to amplify an ompA 
product in any specimens that were positive for the gltA 
gene of R. helvetica.
Sixty-one (77.2%) of 79 Ha. sulcata ticks, 3 (50%) of 6 
Ha. punctata ticks, and 14 (77.7%) of 18 Haemaphysalis spp. 
ticks were positive by PCR for the primer set Rp CS.409p and 
Rp CS.1258n for the gltA gene. The gltA sequences obtained 
were different from all known Rickettsia spp. sequences de-
posited in GenBank. The most closely related sequence of 
gltA was designated “Ricketttsia endosymbiont of Haema-
physalis sulctata” (99.4% similarity; 484/487 bp). The next 
most closely related sequence of gltA, with 96% similarity, 
was R. felis. Results of the PCR with the ompA primer set 
Rr.190.70p-Rr.190.701n were negative for all Haemaphysa-
lis spp. ticks that were positive for the gltA gene.
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Table. Detection and identification of spotted fever group Rickettsia spp. from ticks collected in Morocco, by PCR and DNA sequencing
Tick species (no. specimens 
tested) Host
Rickettsial gene 
targeted/no. ticks positive 
by PCR/no. examined* 
Identification by  
gene sequence  
(no. identified/no. tested) 
GenBank accession 
no.
Dermacentor marginatus (11)  Vegetation gltA/6/11 R. slovaca (5/6),  
R. raoultii  (1/6) 
U59725, DQ365803 
ompA/6/6  R. slovaca (5/6),




Domestic animals gltA/3/35 R. aeschlimannii U59722
ompA/3/3 R. aeschlimannii DQ379982 
Haemaphysalis sulctata (79)  Domestic animals gltA/61/79 “Rickettsia endosymbiont of 
Ha. Sulctata” (“R. kastelanii”)
DQ081187 
ompA/0/61 – –
Ha. punctata  (6)  Domestic animals gltA/3/6 “Rickettsia endosymbiont of 
Ha. Sulctata” (“R. kastelanii”)
DQ081187 
ompA/0/3
Haemaphysalis sp. (18)  Vegetation gltA/14/18 “Rickettsia endosymbiont of 
Ha. Sulctata” (“R. kastelanii”)
DQ081187 
ompA/0/14 – –
Ixodes ricinus  (14)  Vegetation gltA/9/14 R. monacensis (5/9),
R. helvetica (4/9) 
AF140706, U59723 
ompA/5/9 R. monacensis (5/9)  AJ427885
Rhipicephalus sanguineus (106) Domestic animals gltA/5/106 R. massiliae U59720
ompA/5/5  R. massiliae U43792
Rh. bursa (76) Domestic animals gltA/0/76 – –
Rh. turanicus (25) Domestic animals gltA/0/25 – –
*gltA, citrate synthase A; ompA, outer membrane protein A. Only ticks positive for the gltA gene were tested for the ompA gene. RESEARCH
None of the Rh. bursa and Rh. turanicus ticks har-
bored rickettsiae. All GenBank accession numbers used to 
compare sequences obtained from ticks are shown in the 
Table.
Discussion
Before this study, only 2 SFG rickettsiae pathogenic to 
humans had been described in Morocco, R. conorii conorii, 
the agent of Mediterranean spotted fever, and the recently 
described R. aeschlimannii (2,3). In our study, in addition 
to R. aeschlimannii, we identiﬁ  ed 3 other SFG pathogenic 
rickettsiae in Morocco: R. massiliae, R. slovaca, and R. 
monacensis. Furthermore, 2 tick-borne SFG Rickettsia spp. 
presumptively associated with human illnesses, R. helveti-
ca and R. raoultii, and an undescribed bacterium have been 
identiﬁ  ed.
DNA extraction and PCR were performed in different 
locations (Morocco and France), and all results were sup-
ported by 2 sets of primers. The gltA primers used in the 
ﬁ  rst screening are known to amplify all known tick-borne 
rickettsiae (7). A second set of primers targeting the ompA 
gene was used to conﬁ  rm positive results, although some 
rickettsia (e.g., R. helvetica) cannot be ampliﬁ  ed by using 
this set. There were no cases in which multiple species of 
rickettsiae were detected in an infected tick, as in most of 
the similar molecular surveys published (1,2). Our results 
did not address prevalence and distribution of rickettsiae 
detected. Systematic sampling was not conducted. Also, 
some tick samples tested with rickettsial primers have not 
been tested with tick primers in parallel. Therefore, inhibi-
tors that could be responsible for false-negative results and 
underestimation of infection rates cannot be ruled out.
R.  aeschlimannii was isolated from H.  marginatum 
marginatum ticks collected in Morocco in 1997 (3). This 
rickettsia has also been detected in H. marginatum ruﬁ  pes 
ticks in Zimbabwe, Niger, and Mali; in H. marginatum 
marginatum in Portugal, Croatia, Spain, Greece, Algeria, 
and Egypt; and in both ticks in Corsica (2,8,9). H. mar-
ginatum marginatum is also known as the Mediterranean 
Hyalomma and may represent up to 42% of ticks found on 
cattle in Morocco. This tick is also a suspected reservoir 
of R. aeschlimannii because transstadial and transovarial 
transmission have been reported (8). As a result, the distri-
bution of R. aeschlimannii may parallel that of H. margin-
atum marginatum. 
In 2002, the pathogenic role of infection with R. ae-
schlimannii was demonstrated by PCR and serologic test-
ing in a patient who returned to France from Morocco (4). 
Clinical signs in this 36-year-old man were fever, gener-
alized maculopapular rashes, and a vesicular lesion of the 
ankle that became necrotic and resembled the typical tache 
noire of Mediterranean spotted fever. A second case was 
identiﬁ  ed in a patient in South Africa in 2002 (10). This pa-
tient had an eschar around the attachment site. No addition-
al symptoms developed, and treatment with antimicrobial 
drugs may have prevented progression of the syndrome.
A total of 4.7% of the Rh. sanguineus ticks tested were 
infected by R. massiliae. This rickettsia was isolated from 
Rh. sanguineus ticks collected near Marseille, France, in 
1992 (11). It has been also found in Rh. sanguineus and Rh. 
turanicus in Greece, Spain, Portugal, Switzerland, central 
Africa, and Mali (2,12,13). Eremeeva et al. (14) recently 
reported detection and isolation of R. massiliae from 2 of 
20 Rh. sanguineus ticks collected in eastern Arizona in the 
United States. R. massiliae may be commonly associated 
with these ticks, which are distributed worldwide. Trans-
stadial and transovarial transmission of rickettsia in ticks 
has been reported (13). 
In 2003, serologic ﬁ  ndings from Spain showed that in 
5 of 8 serum samples titers against R. massiliae were higher 
than those against R. conorii, the agent of Mediterranean 
spotted fever (12). The authors analyzed clinical symptoms 
of patients with strong serologic reactions against R. massil-
iae antigens but did not ﬁ  nd relevant clinical differences 
between these patients and those with Mediterranean spot-
ted fever. However, it is generally recognized that there are 
relatively few clinical differences among the different spot-
ted fever diseases, and these differences are occasionally 
not taken into account by clinicians when reporting clinical 
data of patients (12). The only conﬁ  rmed case of a person 
infected with R. massiliae was a patient hospitalized in Sic-
ily, Italy. This patient had fever, a maculopapular rash on 
the palms of his hands and the soles of his feet, an eschar, 
and hepatomegaly. The strain of R. massiliae was isolated 
in Vero cells in 1985 and stored for 20 years in Sicily, but 
was not deﬁ  nitively identiﬁ  ed until 2005 at the Unité de 
Rickettsies in Marseille, France (15).
The third SFG pathogenic rickettsia found in our study 
was R. slovaca in 5 (45.5%) of 11 D. marginatus. R. slo-
vaca, which was identiﬁ  ed in Dermacentor spp. ticks in 
Slovakia in 1968, has been subsequently found in D. mar-
ginatus and D. reticulatus in France, Switzerland, Portu-
gal, Spain, Armenia, Poland, Bulgaria, Croatia, Russia, and 
Germany (2,16). These ticks may act as vectors and reser-
voirs of R. slovaca, which is maintained in ticks through 
transstadial and transovarial transmission (17). Human 
infection with R. slovaca was reported in France in 1997. 
Patients with similar clinical signs were observed in Spain, 
Bulgaria, and Hungary, where the syndrome was known 
as tick-borne lymphadenopathy or Dermacentor-borne 
necrosis erythema lymphadenopathy because of eschar at 
the tick bite site in the scalp and cervical lymphadenopathy 
(2,18–20). The incubation period ranges from 4 to 15 days. 
Low-grade fever and rash were present. The acute disease 
can be followed by fatigue and residual alopecia at the bite 
site (16,21). Recently, Gouriet et al. reported 14 new cases 
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with tick-borne lymphadenopathy and Dermacentor-borne 
necrosis erythema lymphadenopathy in southern France 
during January 2004–May 2005 (22). In this group, tick-
borne lymphadenopathy occurred mainly in young children 
and women and during the colder months (22). Overall, 
data in our study indicate that clinicians should be aware 
that this tick-related disorder may be found in Morocco.
R. raoultii is a recently described SFG rickettsia (23). 
In 1999, three new rickettsial genotypes, RpA4, DnS14, 
and DnS28, were identiﬁ  ed in ticks collected in Russia by 
using PCR ampliﬁ  cation and sequencing of 16S rDNA, 
gltA, and ompA genes. Genotypes identical to DnS14, 
DnS28, and RpA4 were thereafter detected in various ar-
eas in Russia and Kazakhstan in D. reticulatus, D. margi-
natus, and D. silvarum (24), in Germany and Poland in D. 
reticulatus (25,26), and in Spain, France, and Croatia in 
D. marginatus (23). Recently, cultivation of 2 rickettsial 
isolates genetically identical to Rickettsia sp. genotype 
DnS14, two rickettsial isolates genetically identical to 
Rickettsia sp. genotype RpA4, and 1 rickettsial isolate ge-
netically identical to Rickettsia sp. genotype DnS28 was 
described (23). These isolates have been shown to ful-
ﬁ  ll the requirements for their classiﬁ  cation within a new 
species, R. raoultii, by using multigene sequencing (16S 
rDNA, gltA, ompA, ompB, sca4, ftsY, and rpoB genes) and 
serotyping techniques (23,27). In our study, we detected 
R. raoultii in D. marginatus in Morocco. This tick is found 
in the cooler and more humid areas of the Mediterranean 
region associated with the Atlas Mountains. It is restricted 
to small areas of Morocco and Tunisia (28). Detection of 
R. raoultii in Morocco is of clinical relevance because it 
is suspected to be a human pathogen. In 2002, it was de-
tected in D. marginatus obtained from a patient in France 
in whom typical clinical symptoms of tick-borne lymph-
adenopathy developed (23).
R. helvetica is another species identiﬁ  ed in Morocco 
in this study. It is one of the few SFG species in which 
a commonly used ompA primer set does not amplify a 
PCR product (7,29). However, sequencing gltA enabled 
deﬁ  nitive identiﬁ  cation. R. helvetica was isolated in Swit-
zerland from I. ricinus in 1979 and has been identiﬁ  ed in 
many European countries, where the tick is both a vec-
tor and a reservoir (2). The distribution of R. helvetica 
is not limited to Europe but extends into Asia (30). Our 
data show that the distribution of this bacterium extends 
into northern Africa. A small population of I. ricinus is 
present in Tunisia, Algeria, and Morocco. Our study was 
conducted in Taza, a humid area in the middle of the Atlas 
Mountains, which was the only site in Morocco that con-
tained I. ricinus ticks (2).
R.  helvetica was considered to be a nonpathogenic 
rickettsia for ≈20 years after its discovery. However, in 
1999 it was implicated in fatal perimyocarditis in patients 
in Sweden (31). The authors of this study subsequently re-
ported a controversial association between R. helvetica and 
sarcoidosis in Sweden (32) and found R. helvetica DNA in 
human aortic valves (33). However, the validity of these 
associations has been questioned by some rickettsiologists 
(2), and additional studies did not detect antibodies to rick-
ettsia in a group of Scandinavian sarcoidosis patients (34). 
In 2000, seroconversion for R. helvetica was described in 
a patient in France with a nonspeciﬁ  c febrile illness (35). 
Serologic data, including cross-absorption and Western 
blotting, supported R. helvetica as the cause of disease. 
During 2003–2007, serologic ﬁ  ndings in tickbite patients 
or in patients with fever of unknown origin from Switzer-
land, Italy, France, and Thailand were suggestive of acute 
or past R. helvetica infection (5,36). The few patients with 
a serology-based diagnosis had relatively mild, self-limited 
illnesses associated with headache and myalgias, and had 
a rash or eschar less frequently. Additional evaluation and 
isolation of the bacterium from clinical samples are needed 
to conﬁ  rm the pathogenicity of R. helvetica.
We have detected in I. ricinus ticks a bacterium known 
as R. monacensis that was isolated from I. ricinus collected 
in 1998 in a park in Munich, Germany (37). This rickett-
sia is also found in the literature by other names such as 
the Cadiz agent found in Spain and Rickettsia IRS3 and 
IRS4, detected in Slovakia and Bulgaria. More recently, it 
has been identiﬁ  ed in I. ricinus in Hungary (38). Recently, 
2 human cases of infection with R. monacensis were docu-
mented in Spain (39). Investigators isolated this agent from 
the blood of 2 patients with Mediterranean spotted fever–
like illnesses. The ﬁ  rst patient was an 84-year-old man 
from La Rioja, Spain. He had fever and maculopapular rash 
without any inoculation eschar. The second patient was a 
59-year-old woman from the Basque region of Spain. She 
had a history of a tickbite, fever, and a rash at the tickbite 
site (39). With our results, R. monacensis joins the list of 
autochthonous Rickettsia spp. conﬁ  rmed as human patho-
gens in Morocco.
A total of 69% of Haemaphysalis  spp. ticks tested 
harbored an incompletely described rickettsia. A closely 
related gltA sequence was found in GenBank as Rickett-
sia endosymbiont of Haemaphysalis sulctata. Duh et al. 
detected this bacterium in Ha. sulcata ticks collected from 
sheep and goats in southern Croatia (40). Using molecular 
analysis of the complete gltA gene and a portion of ompB, 
these authors detected this bacterium in 795 (22.8%) ticks 
tested. Similar to our ﬁ  ndings, these researchers could not 
amplify DNA by PCR for the ompA gene with the primers 
Rr. 190.70-Rr. 190.701. Identiﬁ  cation and isolation of this 
bacterium are needed until the name provisionally proposed 
by Duh et al, “R. kastelanii” (40), is accepted (41).
These  ﬁ  ndings demonstrate that species of ticks and 
several pathogens causing tick-transmitted diseases may 
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be prevalent in the same area. Our study also detected R. 
slovaca, R. helvetica, R. monacensis, R. raoultii, and an in-
completely described rickettsia in Morocco. Clinicians in 
Morocco and those who may see patients returning from this 
country should be aware that many species of rickettsiae are 
present in this region and should consider a range of spotted 
fever rickettsial diseases in differential diagnosis of patients 
with febrile illnesses. Our data increase information on dis-
tribution of SFG rickettsiae in Morocco. Additional studies 
are needed to determine the epidemiologic and clinical rel-
evance of different rickettsioses in this region.
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